Explore › Intervention › Glycemic Control
Intervention

Glycemic Control

Also known as: Blood Glucose Control Control, Blood Glucose Control, Glycemic Glucose Control, Blood Glycemic Control adequate glycemic control (HbA1c <7% for >80% of follow-up time before each landmark)
3 findings 1 paper 4 related entities View in graph →

Related entities

conditions
Metastatic hepatocellular carcinoma1
outcomes
Hepatocellular carcinoma1
populations
Type 2 Diabetes Patients1
studys
PMC91075291

Findings (27)

None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →
None
improvement

In patients with NAFLD and diabetes, maintaining adequate glycemic control (HbA1c <7% for >80% of time) was associated with a 32% lower risk of hepatocellular carcinoma, independent of diabetes medica

Effect: improvement; HR 0.68; CI: 95% CI 0.60-0.77

Size: HR 0.68 CI: 95% CI 0.60-0.77
PMC9107529
Finding details → · Paper → · Graph →

Papers (1)